WHO ICTRP trial
TIming of start of systemIc treatment for asymptomatic MEtastasized PANcreatic…
EUCTR2019-004582-40-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-004582-40-NL |
|---|---|
| Public title | TIming of start of systemIc treatment for asymptomatic MEtastasized PANcreatic cancer |
| Scientific title | TIming of start of systemIc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a randomized controlled multicenter trial - TIMEPAN |
| Primary sponsor | Amsterdam UMC-Location AMC-dept. Internal Medicin |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | Metastasized pancreatic cancer;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Name: Oxaliplatin Pharmaceutical Form: Concentrate for solution for infusion Product Name: Leucovorin Pharmaceutical Form: Concentrate for solution for infusion Product Name: Irinotecan Pharmaceutical Form: Concentrate for solution… |
| Registration date | Mar 2, 2021 |
| Target size | 184 |
| Secondary IDs | TIMEPAN_november_2019 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: